Narayana Hrudayalaya Ltd - 539551 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of schedule of Investor Meeting22-02-2024
22-02-2024
Narayana Hrudayalaya Ltd - 539551 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of schedule of Investor Meeting21-02-2024
Narayana Hrudayalaya Ltd - 539551 - Intimation Regarding Schedule Of Investors Conference
Intimation regarding schedule of Investors Conference20-02-2024
Narayana Hrudayalaya Ltd - 539551 - Audio Recording Of The Earnings Call For The Quarter And Nine Months Period Ended December 31, 2023
Audio Recording of the Earnings Call for the quarter and nine months period ended December 31, 202316-02-2024
Narayana Hrudayalaya Ltd - 539551 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper publication - Unaudited Financial Results for the quarter and nine months ended December 31, 202316-02-2024
Q3FY24 Quarterly Result Announced for Narayana Hrudayalaya Ltd.
Healthcare Facilities company Narayana Hrudayalaya announced Q3FY24 results: Financial Performance: - Consolidated operating revenue for Q3FY24: Rs 12,036 million, a YoY growth of 6.7%. - Consolidated EBITDA for Q3FY24: Rs 2,968 million, an 11.6% increase YoY with a margin of 24.7%. - Consolidated PAT for Q3FY24: Rs 1,881 million, a 22.3% rise YoY with a PAT margin of 15.6%. - India Operating Revenue for Q3FY24: Rs 9,590 million, up by 5.4% YoY. - Cayman Operating Revenue for Q3FY24: Rs 2,576 million, an increase of 11.5% YoY. Operational Highlights: - Total Borrowings less Cash, Bank Balance, and Current Investments: Rs 251 million showcasing a net debt to equity ratio of (0.01). - SRCC Mumbai treated a high-risk pediatric case successfully with a novel therapy. - Mazumdar Shaw Medical Centre (MSMC) in Bengaluru introduced new services and accomplished notable medical procedures, handling 27 Solid Organ Transplants, 44 BMTs, 91 Robotic Procedures, and two rare renal transplants among others. Commenting on the performance, Dr. Emmanuel Rupert, Managing Director and Group CEO, Narayana Hrudayalaya, said “After a strong second quarter, the third quarter of the fiscal year delivered a steady performance across our business units with a healthy YoY growth. The QoQ growth was impacted on account of festivals-related holidays in the current quarter. HCCI continues to contribute significantly to the overall performance and the new initiatives continue to see good traction. The new entity NHIC has delivered strong growth this quarter led by increased collections and steady inflow of patient transactions, remaining on track as per the plan.” Result PDF15-02-2024
Narayana Hrudayalaya down 4%
Narayana Hrudayalaya reported a 6.7 percent year-on-year increase in revenue at Rs 1,203.6 crore15-02-2024
Narayana Hrudayalaya Ltd - 539551 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investor Presentation for the quarter ended December 31, 202314-02-2024
Narayana Hrudayalaya Ltd - 539551 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release for the quarter ended December 31, 202314-02-2024
Narayana Hrudayalaya Ltd - 539551 - Board Meeting Outcome for Unaudited Financial Results For The Quarter Ended December 31, 2023
Unaudited Financial Results for the quarter ended December 31, 202314-02-2024